Correlation Between Organ-specific Co-morbidities and Complications in Bladder Cancer Patients Undergoing Radical Cystectomy
Overview
Authors
Affiliations
Objective: To evaluate the association between patients' organ-specific co-morbidities and post-operative complications following radical cystectomy for bladder cancer.
Patients And Methods: All patients who underwent radical cystectomy at Aarhus University Hospital during the period from January 2006 to February 2014 were included retrospectively. A total of 40 comorbidities and 59 complications were registered meticulously. Univariate and multivariate analyses were used to detect associations between the individual comorbidities and specific post-operative complications.
Results: Ninety-two per cent (575/625) of patients experienced one or more complications following radical cystectomy. Clavien-Dindo grade 3-5 complications were observed in 40.8% of patients, and 6.2% had severe complications (Clavien-Dindo grade 4-5). The mortality rate was 2.2%. High BM, previous myocardial infarction and chronic obstructive pulmonary disease were noted to be associated with moderate-to-severe post-operative complications (Clavien-Dindo grade 3-5), while diabetes and lymphoproliferative disorders were significantly associated with severe complications (Clavien-Dindo grade 4-5).
Conclusion: This study demonstrates that overall complications to radical cystectomy are high (92%). The associations between specific comorbidities and complications need to be further investigated in order to evaluate whether pre-operative assessment can be more optimally used in a prevention strategy tailored to the individual patient.
Ureteroenteric strictures after cystectomy: Side-specific risk factors and radiological assessment.
Brandt S, Ibsen L, Lam G, Bottcher M, Kingo P, Jensen J BJUI Compass. 2024; 5(7):699-708.
PMID: 39022665 PMC: 11250374. DOI: 10.1002/bco2.364.
Brandt S, Korner S, Milling R, Nielsen N, Kingo P, Joensen U Eur Urol Open Sci. 2024; 60:8-14.
PMID: 38375343 PMC: 10874842. DOI: 10.1016/j.euros.2023.12.007.
Abdelrahman I, Aboulkassem H, Elazab A, Abdallah A, Ismail Y, Taher M J Egypt Natl Canc Inst. 2023; 35(1):13.
PMID: 37145329 DOI: 10.1186/s43046-023-00175-2.
Jensen B, Thomsen T, Mohamed N, Paterson C, Goltz H, Retinger N Asia Pac J Oncol Nurs. 2022; 9(7):100046.
PMID: 35662875 PMC: 9160473. DOI: 10.1016/j.apjon.2022.02.008.
Jensen B, Retinger N, Lauridsen S Asia Pac J Oncol Nurs. 2022; 9(7):100048.
PMID: 35647225 PMC: 9136268. DOI: 10.1016/j.apjon.2022.02.010.